Rx-to-OTC switch guidelines recommended in Senate FDA reform report language.
This article was originally published in The Tan Sheet
Executive Summary
Rx-TO-OTC SWITCH GUIDELINES RECOMMENDED IN REPORT LANGUAGE accompanying Sen. Nancy Kassebaum's (R-Kan.) FDA reform bill (S 1477) filed with the Senate June 20. The report states that the Committee on Labor & Human Resources, which Kassebaum chairs, "expects that FDA, as part of its mission of...`facilitating the rapid and efficient availability of products subject to its regulation,' will establish appropriate procedures and policies, including performance standards, to expedite the review" of Rx-to-OTC switches.